Evidence map›Paper›PMID 37144982›Full record

ArticleCarcinogenesis2023

TERT and BRAF V600E mutations in thyroid cancer of World Trade Center Responders.

Maaike van Gerwen, Janete Maria Cerutti, Thais Biude Mendes, Rachel Brody, Eric Genden, Gregory J Riggins, Emanuela Taioli

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Maaike van GerwenDepartment of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-0568-7388
Janete Maria CeruttiGenetic Bases of Thyroid Tumor Laboratory, Division of Genetics, Department of Morphology and Genetics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Pedro de Toledo 669, 11 Andar, São Paulo, 04039-032 SP, Brazil.
Thais Biude MendesGenetic Bases of Thyroid Tumor Laboratory, Division of Genetics, Department of Morphology and Genetics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Pedro de Toledo 669, 11 Andar, São Paulo, 04039-032 SP, Brazil.
Rachel BrodyDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Eric GendenDepartment of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Gregory J RigginsDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Emanuela TaioliInstitute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0001-5734-4806
Icahn School of Medicine at Mount Sinai · USUniversidade Federal de São Paulo · BRJohns Hopkins University · US

Funding

THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANTP30CA196521 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ramon E Parsons · 2015 to 2026
$35.4M
Thyroid Cancer Aggressiveness in WTC RespondersU01OH011849 · OH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI RIGGINS, GREGORY JOSEPH, TAIOLI, EMANUELA · 2019 to 2020
$2.0M
ACL HHS U01OH011704NCI NIH HHS P30 CA196521NIOSH CDC HHS U01 OH011849
6 · The paper itself

Abstract

The 2-fold excess thyroid cancer risk reported in multiple World Trade Center (WTC) disaster exposed cohorts cannot entirely be explained by surveillance and physician bias thus highlighting the need to investigate the potential consequences of the dust exposure, containing carcinogenic and endocrine disruptive elements, on the thyroid. This study investigated the presence of TERT promoter and BRAF V600E mutations in 20 WTC-exposed versus 23 matched non-exposed thyroid cancers as potential mechanism explaining the excess risk. Although no significant difference in BRAF V600E mutation was found, TERT promoter mutations were significantly more prevalent in WTC thyroid cancer versus non-exposed thyroid cancers (P = 0.021). The odds of a TERT promoter mutation was significantly higher in the WTC versus the non-WTC thyroid cancers after adjustment [ORadj: 7.11 (95% CI: 1.21-41.83)]. These results may indicate that exposure to the mixture of pollutants present in the WTC dust resulted in an excess thyroid cancer risk and potentially more aggressive thyroid cancer, warranting investigating WTC responders on thyroid-associated symptoms during their health checkups. Future studies should include long-term follow-up to provide important insights in whether thyroid-specific survival is negatively affected by WTC dust exposure and whether this is because of the presence of one or more driver mutations.

Indexed as

TelomeraseThyroid NeoplasmsHumansMutationPromoter Regions, GeneticProto-Oncogene Proteins B-rafThyroid Cancer, PapillaryBRAF protein, humanProto-Oncogene Proteins B-rafTelomeraseTERT protein, human

Identifiers

PMID37144982
PMCPMC10290513
OpenAlexW4372291811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.